The U.S. Food and Drug Administration (FDA) is due to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week, despite side effects linked to its mRNA technology.
The U.S. Food and Drug Administration (FDA) is due to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week, despite side effects linked to its mRNA technology.